Oxaliplatin acts on IB4-positive nociceptors to induce an oxidative stress-dependent acute painful peripheral neuropathy
- PMID: 18359667
- DOI: 10.1016/j.jpain.2008.01.335
Oxaliplatin acts on IB4-positive nociceptors to induce an oxidative stress-dependent acute painful peripheral neuropathy
Abstract
The toxicity profile of oxaliplatin, a platinum derivative currently used in the treatment of colorectal cancer, differs from those of the other platinum compounds, cisplatin and carboplatin. Oxaliplatin treatment induces an acute neurotoxicity characterized by a rapid onset of cold-induced distal dysesthesia and a chronic sensory peripheral neuropathy. A single intravenous dose of oxaliplatin produced a dose-dependent mechanical hyperalgesia and heat and cold allodynia; repeated administration intensified symptoms. A single intradermal dose of oxaliplatin produced a dose-dependent mechanical hyperalgesia. A single dose intravenous oxaliplatin also lowered thresholds and increased responses of C-fiber nociceptors to mechanical stimulation, confirming a peripheral site of action. Whereas peripheral administration of inhibitors of second messengers implicated in models of other painful peripheral neuropathies (PKA, PKC, NO, Ca(2+), and caspase) had no effect; both systemic and local administration of antioxidants (acetyl-L-carnitine, alpha-lipoic acid or vitamin C), all markedly inhibited oxaliplatin-induced hyperalgesia. Intrathecal administration of the neurotoxin for IB4-positive nociceptors, IB4-saporin, markedly attenuated IB4 staining in the dorsal horn of the spinal cord and completely prevented oxaliplatin-induced hyperalgesia. We suggest that oxaliplatin acts on IB4 (+)-nociceptors to induce oxidative stress-dependent acute peripheral sensory neuropathy.
Perspective: Many drugs used to treat cancer produce pain as their dose-limiting side effect. We used a model of this pain syndrome induced by oxaliplatin to demonstrate that pain is produced by action on a subset of nociceptors, the IB4-positive DRG neurons. This information could help define cellular targets against which protective therapies could be developed.
Similar articles
-
Oxaliplatin-induced neuropathy in the rat: involvement of oxalate in cold hyperalgesia but not mechanical allodynia.Pain. 2009 Dec 15;147(1-3):165-74. doi: 10.1016/j.pain.2009.09.003. Epub 2009 Sep 25. Pain. 2009. PMID: 19782472
-
Characterization of acute and chronic neuropathies induced by oxaliplatin in mice and differential effects of a novel mitochondria-targeted antioxidant on the neuropathies.Anesthesiology. 2014 Feb;120(2):459-73. doi: 10.1097/01.anes.0000435634.34709.65. Anesthesiology. 2014. PMID: 24064792
-
The behavioral and neuroanatomical effects of IB4-saporin treatment in rat models of nociceptive and neuropathic pain.Brain Res. 2004 Dec 10;1029(1):65-76. doi: 10.1016/j.brainres.2004.09.027. Brain Res. 2004. PMID: 15533317
-
[Role of Transient Receptor Potential Channels in Paclitaxel- and Oxaliplatin-induced Peripheral Neuropathy].Yakugaku Zasshi. 2016;136(2):287-96. doi: 10.1248/yakushi.15-00214. Yakugaku Zasshi. 2016. PMID: 26831807 Review. Japanese.
-
Chemotherapy-induced peripheral neuropathy: What do we know about mechanisms?Neurosci Lett. 2015 Jun 2;596:90-107. doi: 10.1016/j.neulet.2014.10.014. Epub 2014 Oct 22. Neurosci Lett. 2015. PMID: 25459280 Review.
Cited by
-
A novel and selective poly (ADP-ribose) polymerase inhibitor ameliorates chemotherapy-induced painful neuropathy.PLoS One. 2013;8(1):e54161. doi: 10.1371/journal.pone.0054161. Epub 2013 Jan 10. PLoS One. 2013. PMID: 23326593 Free PMC article.
-
Oxidative stress in the development, maintenance and resolution of paclitaxel-induced painful neuropathy.Neuroscience. 2016 Oct 1;333:13-26. doi: 10.1016/j.neuroscience.2016.06.050. Epub 2016 Jul 5. Neuroscience. 2016. PMID: 27393249 Free PMC article.
-
Pretreatment with Zonisamide Mitigates Oxaliplatin-Induced Toxicity in Rat DRG Neurons and DRG Neuron-Schwann Cell Co-Cultures.Int J Mol Sci. 2022 Sep 1;23(17):9983. doi: 10.3390/ijms23179983. Int J Mol Sci. 2022. PMID: 36077386 Free PMC article.
-
Isolectin B4 (IB4)-conjugated streptavidin for the selective knockdown of proteins in IB4-positive (+) nociceptors.Mol Pain. 2024 Jan-Dec;20:17448069241230419. doi: 10.1177/17448069241230419. Mol Pain. 2024. PMID: 38246917 Free PMC article.
-
Transient Receptor Potential Vanilloid 1 is essential for cisplatin-induced heat hyperalgesia in mice.Mol Pain. 2010 Mar 5;6:15. doi: 10.1186/1744-8069-6-15. Mol Pain. 2010. PMID: 20205720 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous